Sekhmet Pharmaventures has announced the appointment of Agarwal Mukesh as its Chief Financial Officer (CFO), strengthening the company’s financial leadership as it expands across India’s dynamic pharmaceutical sector.

Mukesh brings over 20 years of experience in financial strategy, governance, and risk management within leading pharmaceutical organizations. His expertise spans APIs, R&D, and global operations, equipping him to drive Sekhmet’s financial planning, operational efficiency, and strategic growth initiatives.

Prior to joining Sekhmet, Mukesh served as CFO at MACLEODS PHARMACEUTICALS LTD. and ZCL Chemicals Ltd (now Cohance Lifesciences). He has also held senior finance roles at Cipla, Wockhardt Ltd., and Ipca Laboratories Limited, consistently delivering impactful results in complex, highly regulated environments.

In his new role, Mukesh will oversee financial strategy, risk management, and governance, ensuring Sekhmet’s robust growth trajectory while fostering innovation and operational excellence. His appointment reflects the company’s commitment to building strong leadership for the next phase of expansion in India’s pharmaceutical landscape.

CXO TechBOT wishes Mukesh Agarwal great success in this new role.